News

On May 12, at the European Medicines Verification Organisation’s (EMVO) General Assembly meeting, the NMVO Observers within EMVO’s Board for 2023 from the National Medicines Verification Organizations (NMVOs) were approved. As one of the observers representing the group of small-scale countries, will be the Latvian Medicines Verification Organisation (LZVO) and its Chairwoman of the Board Inese Erdmane.

The European Medicines Verification Organisation (EMVO) has launched a newsletter, which looks back on the past four years of the verification system’s operation, informs about the launch of the European Alert Management System (EAMS) and provides an opportunity to look into the first European Medicines Verification System’s (EMVS) forum, which was also attended by the Latvian Medicines Verification Organisation (LZVO) representatives Inese Erdmane and Andra Pučko.

Lielbritānijas valdības un Eiropas Komisijas 27. februārī panāktā vienošanās par tirdzniecības nosacījumiem starp Lielbritāniju un Ziemeļīriju ietekmēs arī līdzšinējo zāļu verifikācijas sistēmu.

On February 22, the Latvian Medicines Verification Organisation (LZVO) held a free seminar for manufacturers of medicines or marketing authorization holders (MAH) on the current developments related to the medicines verification system in Latvia and a look back on what was done in 2022.

To inform marketing authorization holders (MAHs) about the current events, the Latvian Medicines Verification Organisation (LZVO) will hold a special seminar on February 22, 2023.

Informējam, ka servisu darbība ir atjaunota un nereģistrēto problēmu verifikācija ir iespējama atkal bez būtiskiem traucējumiem.